Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life. Reumatismo, [S. l.], v. 72, n. 2, p. 71–74, 2020. DOI: 10.4081/reumatismo.2020.1267. Disponível em: https://www.reumatismo.org/reuma/article/view/1267. Acesso em: 2 jun. 2025.